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Background: We tried to compare the functional and psychosocial outcomes after various reconstruction methods
according to tumor location following resection of osteosarcoma in distal femur.
Methods: We retrospectively reviewed 51 patients who underwent limb-salvage surgery of osteosarcoma in distal
femur in our institution, 30 males and 21 females with an average age of 21 years (range 13–51 years). We classified
osteosarcoma in distal femur into 3 types, and organized affected limb reconstruction methods after wide resection.
MSTS and QOL scores were used to analyze the functional and psychological outcomes.
Results: After a mean follow-up of 43 months (12–225 months), there is no difference on functional results and
QOL scores among three reconstruction groups (p > 0.05) and among three types groups (p > 0.05). No difference
could be noticed on tumor-free survival and total survival among three reconstruction groups (p > 0.05) and three
type groups (p > 0.05). In ≤2-year, better functional scores could be found in prosthesis group, rather than the other
two inactivated-bone groups (p < 0.05).
Conclusions: Biological reconstruction with alcohol-inactivated autograft replantation could avoid prosthesis related
complications and achieved comparable results with prosthesis following resection of osteosarcoma in distal femur.
Different reconstruction options could be chosen according to tumor location, such as the distance to Insall line.
Keywords: Osteosarcoma, Reconstruction, Limb function, Quality of life, Alcohol-inactivated autograft replantation,
Articulation preservation, Prosthesis replacementBackground
Osteosarcoma, the most common primary malignant bone
tumor, usually arises in the metaphysis of long bones such
as the distal femur, during the second decade of life [1].
Due to the various anatomical factors unique to juxta-
articular osteosarcomas around the knee, the reconstruc-
tion in distal femur remains a challenging problem. Greater
understanding of the functionality and quality of life of the
osteosarcoma survivor has the potential to impact treat-
ment decision-making and provision of follow-up services.
In addition, few studies have described the application of* Correspondence: yxch48@vip.sina.com
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tion of osteosarcoma in distal femur.
We classified osteosarcoma in distal femur encoun-
tered at our department into 3 types according to the
location of the tumor by preoperative MRI, and orga-
nized affected limb reconstruction methods after wide
resection. We performed this study to compare the
functional and psychosocial outcomes of limb-salvage
surgery after various reconstruction methods accord-
ing to tumor location following resection of osteosarcoma
in distal femur. The other purpose was to determine
whether the reconstruction option of alcohol-inactivated
autograft replantation could be comparable with pros-
thesis following resection of osteosarcoma in distal femur.is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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The retrospective collection of clinical data and the publi-
cation of the data were in accordance with local guidelines
for research ethics and were approved by the research eth-
ics committee of General Hospital of Ji’Nan Military
Region, Ji’Nan. All patients were treated by the same
chief surgeon (XCY) and his assistants (SFX and MX)
in the same institute. Written informed consent for
participation in the study was obtained from all pa-
tients, including permission to access patient records
and to publish individual clinical details. All procedures
were in compliance with the Helsinki Declaration.
We retrospectively reviewed 51 patients who underwent
limb-salvage surgery of osteosarcoma in distal femur at
our institution, and were at least 12 years old at the time
of operation. All patients received a diagnosis of osteosar-
coma by biopsy and pathology. The surgery had been car-
ried out between May 1995 and November 2012.
There were 30 males and 21 females with an average
age of 21 years (range 13–51 years). 47 were under
30 years. One patient was with lung node and the other
one with lung metastasis diagnosed by biopsy. No patients
were with pathological fracture.
Preoperative chemotherapy was performed 2 times on
a neoadjuvant basis. Two chemotherapy protocols were
used: the DIA [2] and MMIA protocols [3]. Evidence of
good chemotherapeutic response consisted of sclerotic
changes or good margin of the tumor observed on plain
radiographs, marked shrinkage of tumors extending into
soft tissue on MR images.
Operative treatment
Surgical technique followed standard oncologic principles
of segmental resection as previously described [4]. Alcohol-
inactivated autograft replantation was used in selective
cases. Ligaments and tendons were reattached if possible,
but this varied on a case-by-case basis. 10 patients had
experienced alcohol-inactivated autograft replantation
with articulation preservation, and 11 experienced alcohol-
inactivated bone replantation without articulation preser-
vation. Internal plate, screw, and intramedullary nail were
used as internal fixations in inactivated autograft replanta-
tion [5]. The other 30 patients had experienced custom-
made rotating hinged knee prosthesis (LiDaKang, BeiJing,
China) replacement.
The conventional anterormedial incision encircling the
biopsy scar for the knee was used. The surgical tech-
nique, taking the inactivated autograft replantation with
articulation preservation as a sample, was described as
follows [6]: (1) The lesion in distal femur was resected
according to tumor-free technique rules at least 1 cm
over tumor boundary, and the distal articular surface
below Insall line was preserved according to preopera-
tive MRI. (2) Then soft tissue and extraosseous tumorwere cleared off. The medullar cavity was reamed and
intraosseous tumor was curetted. (3) Preliminary screw fix-
ation was prepared. The prepared autograft was then im-
merged into 99% alcohol for 30 minutes, retrieved and
flushed with 3000 ml physiological saline. (4) The intrame-
dullary nail was inserted into the inactivated bone off the
table by carefully pressurizing cement into the inactivated
bone, using the operator’s thumb to occlude the proximal
medullar canal. Any excess cement was removed from the
protruding stem of the femoral component and from the
distal end of the inactivated bone. (5) After cylindrical
reaming of the proximal femur, the intramedullary nail was
inserted and cemented. (6) Before polymerization of the ce-
ment, the inactivated autograft was fixed quickly into the
distal preserved articular surface with screws through previ-
ously prepared cross screw route. Care was taken so no ce-
ment was caught between the inactivated autograft and the
host bone. If possible, it is recommended that autogenous
iliac bone grafts were placed at the inactivated autograft-
host bone junction to form extracortical grafting.
Tumor location
Tumor location in distal femur was classified into 3 types
by the extension of osteosarcoma according to preopera-
tive MRI (Figure 1). The extension of the tumor was eval-
uated on T1-weighted, T2-weighted, and Gd-enhanced
T1-weighted MRI images in coronal, sagittal, and axial
planes.
1. Type I
Type I tumors were those located in the diaphysis at
a distance of ≥ 1 cm from the Insall line. There were
8 patients with this type (Figure 2). Reconstruction
in 7 patients was performed using inactivated
autograft replantation with articulation preservation,
and in 1 patient diagnosed as parosteal
osteosarcoma without neoadjuvant chemotherapy
using inactivated autograft replantation without
articulation preservation.
2. Type II
Type II tumors were those located in contact with
the Insall line or within 1 cm from this line. There
were 14 patients with this type (Figure 3).
Reconstruction in 3 patients was performed using
inactivated autograft replantation with articulation
preservation (Figure 4), and in 9 patients using
inactivated autograft replantation without
articulation preservation. In the other 2 patients
with severe bone destruction, the custom-made
rotating hinged knee prosthesis was used.
3. Type III
Type III tumors were those extending from the
diaphysis to the epiphysis beyond the Insall line.







Figure 1 Classification of tumor location according to preoperative MRI. Type I (a), tumors located in the diaphysis at a distance of ≥ 1 cm
from the Insall line. Type II (b), tumors located in contact with the Insall line or within 1 cm from this line. Type III (c), tumors extended from the
diaphysis to the epiphysis beyond the Insall line.
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using the custom-made rotating hinged knee prosthesis
in all patients, one of whom was with lung metastasis.Postoperative treatment
Prophylactic antibiotics were administered for 48 hours.
Low-molecular-weight heparin was administered for 2 weeks
in prosthesis group and none in inactivated-replantationure 2 A 20-year-old male patient with osteosarcoma in left distal f
h articulation preservation. a Preoperative MRI showed intramedullar
2cm over Insall line which was classified as Type I. b-d Postoperative X
nthes after operation, X-ray showed bone callus in diaphysis, and bony
nths after operation, X-ray showed fully bony healing and good joint sp
STS score and 53 in QOL.group. For postoperative treatment, patients in prosthesis
group were placed on bed for 1 week without external brace
and in inactivated-bone group on bed for 6 weeks with ex-
ternal brace. After that, partial weight bearing was allowed
initially, and then weight-bearing using two elbow crutches
was allowed. Full weight bearing with no support was
allowed at the end of 3 months in prosthesis group
and 6 months in inactivated-replantation group. Plainemur was treated with alcohol-inactivated autograft replantation
y low mixed signal in T1 in distal femur. The lowest boarding of tumor
-ray at 1 week, 3 months and 6 months. e and f 16 months and 20
healing in conjunction between host bone and inactivated bone. g 35
ace. At the end of follow-up, he has returned to normal work with 33
Figure 3 A 15-year-old female patient with osteosarcoma in right distal femur was treated with alcohol-inactivated autograft replantation
with articulation preservation. a. Preoperative MRI showed intramedullary high and low mixed signal in distal femur. The tumor lies near Insall line
which was classified as Type II. b. Preoperative X-ray showed osteolytic bone destruction in distal femur, in accompany with severe bone destruction
in lateral cortical bone, local soft tissue mass and periosteal reaction. c. Postoperative X-ray showed significantly reduced osteolytic bone destruction in
distal femur, in accompany with local soft tissue mass disappearance and restoration of the continuity of the lateral periosteum. d. Two months after
operation, X-ray showed bone callus in diaphysis, and bony healing in conjunction between host bone and inactivated bone. e. 110 months after
operation, X-ray showed fully bony healing and good joint space.
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were done every 3 months for two years, bi-annually
for a further three years and annually thereafter.
Except one who refused chemotherapy administration, all
were administered chemotherapy 6 times postoperatively
with two protocols: the DIA and MMIA protocols [3].
Functional assessment
Limb function was evaluated with the Musculoskeletal
Tumor Society (MSTS) rating scales, which comprise sevenFigure 4 A 15-year-old male patient with osteosarcoma in left distal f
with articulation preservation. a. Preoperative MRI showed intramedullar
tumor lies 2cm over Insall line which was classified as Type I. b. Preoperativ
with severe bone destruction in lateral cortical bone, local soft tissue mass an
osteolytic bone destruction in distal femur, in accompany with local sof
lateral periosteum. d. Two weeks after operation, X-ray showed repositio
e. Nine months after operation, X-ray showed diaphysis fracture and bon
f. 30 months after reoperation, X-ray showed fully bony healing and gooitems, namely motion, pain, stability, deformity, strength,
functional activity and emotional acceptance. The highest
possible score is 35 and 5 points being allocated to each
item [7]. According to the follow-up period, it was divided
into ≤2-year group and >2-year group.
Quality of life assessment
The Quality of Life (QOL)—modified specific scale for
Chinese cancer patient [2] is a 12-item questionnaire
that measures quality of life (appetite, sleep quality, pain,emur was treated with alcohol-inactivated autograft replantation
y high and low mixed signal in distal femur. The lowest boarding of
e X-ray showed osteolytic bone destruction in distal femur, in accompany
d periosteal reaction. c. Postoperative X-ray showed significantly reduced
t tissue mass disappearance and restoration of the continuity of the
n of inactivated bone with outside cortical allograft bone bridging.
y healing in conjunction between host bone and inactivated bone.
d joint space.
Figure 5 A 17-year-old female patient with osteosarcoma in left
distal femur was treated with prosthesis replacement. a 8 years
after operation, bone lose and prosthesis loosening could be found
on X-ray. Physical examination demonstrated 6 cm limb length
discrepancy with 26 in MSTS score and 44 in QOL. b After prosthesis
revision, the left lower limb alignment restored and 3 cm limb length
discrepancy remained.
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fatigue, spiritual well-being, cancer knowledge, attitude
to treatment, understanding and cooperation of family
members and colleagues). Each item is rated on a 5-point
Likert-type scale. The total score is 60. The results are ≤
20 (very poor), 21–30 (poor), 31–40 (fair), 41–50 (good),
and 51–60 (very good). High scores indicate good quality
of life. According to the follow-up period, it was divided
into ≤2-year group and >2-year group.Statistics
Summary statistics were calculated for patient character-
istics by type and reconstruction groups. Chi-square
tests of independence were used to assess group differ-
ences in sex and race. Median tests were used to assess
group differences in age at diagnosis, duration from
diagnosis to study participation, and age at the time of
study participation. Means, standard deviations (SDs),
and confidence intervals were calculated for each func-
tional and psychological outcome variable by type and
reconstruction groups. Multiple linear regression models
were used to examine differences in functional and psy-
chological outcomes among the three patient groups
and three type groups after adjusting for duration from
diagnosis to study participation.
Results
The mean follow-up was 43 months ranging from 12 to
225 months. 21 were followed for more than 2 years,
and 12 for more than 5 years. 2 patients experienced
inactivated-bone fracture and reoperation with internal
fixation. 4 patients experienced prostheses loosening
ranging from 17 to 99 months after operation in pros-
thesis group. 11 experienced recurrence ranging from
4 to 29 months after operation. The mean recurrence
time was for 12.5 months. 23 experienced metastasis
ranging from 5 to 44 months after operation. The
mean metastasis time was for 19.8 months. Local in-
fection is 5/29 (17.2%) and prosthesis loosening is 4/29
(13.8%).
There is no difference on functional results and QOL
scores among three reconstruction groups (p > 0.05). Mean-
while, there is no difference on functional results and QOL
scores among three types groups (p > 0.05). There is no dif-
ference on tumor-free survival and total survival among
three reconstruction groups (p > 0.05) and three type groups
(p > 0.05) (Figure 6).
In ≤2-year, better functional scores could be found in
prosthesis group, rather than the other two inactivated-
bone groups (p < 0.05). In >2-year, no difference in func-
tional and QOL scores could be found among three
groups (p > 0.05). However, lower incidence of prosthesis
related complications could be found in inactivated-
replantation group, whatever articulation preservation.
No relationship could be found between functional re-
sults and QOL (p > 0.05) whenever in ≤2-year group or
in >2-year group.
Reconstruction after tumor resection was performed
by inactivated-bone replantation with articulation pres-
ervation in 10 patients. There were 7 males and 3 fe-
males, ranging in age from 15 to 34 years (mean,
21 years). Tumors were Type I in 7 patients, Type II in 3
patients. Two experienced inactivated bone fracture and
reoperation with internal fixation 7 and 8 months after
Figure 6 Kaplan-Meier survival curves showing survival by 3 reconstructions (a) and by 3 types (b) in patients following resection of
osteosarcoma in distal femur. There is no difference on tumor-free survival and total survival among three reconstruction groups (p < 0.01) and
three type groups (p < 0.01).
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One experienced arthroscopic release for knee stiffness.
At the end of follow-up, 6 patients had died due to mul-
tiple metastases after a mean of 14 months, ranging from
5 to 29 months. The MSTS score in ≤2-year is 22.6 (63%),
and in >2-year is 26.3 (73%). QOL in ≤2-year is 28.8, and
in >2-year is 40.8.
Reconstruction was performed by alcohol-inactivated
autograft replantation without articulation preservation
in 12 patients. There were 6 males and 6 females, ranging
in age from 14 to 34 years (mean, 19 years). Tumors were
Type I in 1 patient, Type II in 9 patients and Type III
in 2 patients. No inactivated bone fracture occurred.
Recurrence occurred in 5 patients who experienced
metastases lately, ranging from 7 to 16 months (mean,
12.2 months). 2 were treated with custom-made rotating
hinged knee prosthesis replacement and hip disarticula-
tion respectively. The MSTS score in ≤2-year is 23.3
(64%), and in >2-year is 28.2 (78%). QOL in ≤2-year is
30.8, and in >2-year is 42.3.
Reconstruction was performed by custom-made rotat-
ing hinged knee prosthesis reconstruction in 29 patients.
There were 18 males and 11 females, ranging in age
from 13 to 51 years (mean, 21 years). Tumors were Type
II in 2 patients with severe bone destruction and Type
III in other 27 patients. Prosthesis loosening occurred in
4 patients. Infection occurred in 5 patients, 2 of who ex-
perienced skin ulcer and reoperation of muscle flap
transposition. Recurrence occurred in 6 patients. At the
end of follow-up, 12 patients had died due to multiple
metastases after a mean of 26.5 months, ranging from 6
to 44 months. The MSTS score in ≤2-year is 27.6 (76%),
and in >2-year is 26.7 (74%). QOL in ≤2-year is 46.8,
and in >2-year is 45.4.Discussion
When the affected limb is reconstructed after the resection
of a malignant tumor in adolescence, such reconstruction
is associated with a variety of problems, including an ex-
pectation of joint function due to postoperative articulation
preservation, measures to be taken to cope with high
levels of physical activity, and problems related to so-
cial adaptation. In other side, there are various limb
reconstruction methods for malignant bone tumors in
distal femur, and each method has advantages and dis-
advantages. There is no optimal good reconstruction
method for each patient.
To solve these problems, we attempted to classify re-
construction of the lower limbs into 3 types based on the
sites of tumor location in distal femur on MRI (Figure 1).
This classification served as a guide for the resection mar-
gins and the available choice of different reconstruction
methods of in distal femur. Type I tumors were those
located in the diaphysis. Type II tumors were those in
contact with the Insall line, and Type III tumors were
those infiltrating the epiphysis through the Insall line.
In our opinion, the first type involves reconstruction of
the long bone shaft, alcohol-inactivated autograft replan-
tation with articulation preservation is recommended to
be the most useful technique. This approach is apparently
applicable to reconstruction of the diaphysis, and has less
influence on limb function associated with malignant bone
tumor resection in distal femur. For Type II tumors,
which are located in the diaphysis in contact with Insall
line, when adjunctive therapies such as chemotherapy
are effective, there is a chance of preserving the articu-
lation. If impossible, alcohol-inactivated autograft replan-
tation without articulation preservation is recommended,
which may results in joint surface degeneration and joint
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epiphyses that require an adequately wide resection with
margins of at least 3 cm in the surrounding tissue. This
type is an indication for wide resection and prosthesis re-
placement. The results showed that this classification can
be successfully used as a guide for appropriate decision-
making in all cases following resection of osteosarcoma in
distal femur.
According to Manfrini’s [8] report, if preoperative
MRI demonstrated no invasion of malignant tumor
into epiphysis, the limb-salvage surgery with epiphysis
preservation should be considered for better limb func-
tion. Similarly, Yoshida et al. [9] classified reconstruction
of the lower limbs in pediatric malignant bone tumors
into 3 types according to preoperative MRI, and emphy-
sized that a limb reconstruction method allowing the
maximal preservation of joint function should be selected
after careful evaluation of the effects of chemotherapy and
the location of the tumor. The reason why we chose Insall
line were that : first, Insall line lies near epiphyseal line;
second, it is easy for intraoperative localization; third, it
would be convenient for preservation of lateral and medial
collateral ligament which do good for knee joint in-
stability. In our previous management of 7 malignant
bone tumor around knee, it was showed that alcohol-
inactivated autograft replantation with articulation preserva-
tion could improve the short-term limb function, avoiding
complications with prosthesis [10].
Neoadjuvant chemotherapy is the breakthrough for
treatment of osteosarcoma, which could destroy the pri-
mary tumor and achieve safe surgical resections. Disease
free survival was escalated from <20% prior to the intro-
duction of effective chemotherapy to 55–75% and overall
survival to 85% [11]. Further, the opportunity to perform
limb salvage was expanded to 80% of patients [11]. The
introduction of chemotherapy to the treatment of osteo-
sarcoma caused a paradigm shift in surgical procedure
[12]. Efficient chemotherapy has made long survival pos-
sible after excision of osteosarcoma and has helped to
minimize the surgical margins. After effective preopera-
tive chemotherapy, osteosarcoma can be excised with
the preservation of a maximum of healthy tissue, such
as ligaments and tendons. In our previous practice, with
careful preoperative evaluation and effective preopera-
tive chemotherapy marginal resection of osteosarcoma
can produce good results [3]. On this consideration, 3
patients of Type II experienced marginal resection and
inactivated autograft replantation with articulation pres-
ervation, after careful evaluation of good chemothera-
peutic response.
Achieving complete ablation of the tumor and preserv-
ing a functional extremity at the same time proves to be
a difficult task due to the various anatomical factors
unique to distal femur. The most popular reconstructivemethods are prosthesis and biological reconstruction.
Prosthesis has been recommended as an optimal recon-
struction choice after resection of juxta-articular osteo-
sarcoma around the Knee [13]. Prosthesis failures are
classified as soft-tissue failures, aseptic loosening, struc-
tural failures, infection, and tumor progression [14]. Deep
infection is the most serious of these complications and
the infection rate for patients undergoing endoprosthetic
implantation is between 3.6% and 44.6% [14,15]. In this
study, local infection is 5/29 (17.2%) and prosthesis
loosening is 4/29 (13.8%). There is no difference among
three type groups and three reconstruction groups in
over-2-year on functional results and QOL. While in
inactivated-bone group whenever articulation preserva-
tion, no infection occurred. However, none of prosthesis
related complications could be found in inactivated
autograft group, whatever articulation preservation, dem-
onstrated that biological reconstruction with inactivated-
bone could avoid prosthesis related complications and
achieved comparable results with prosthesis. This recon-
struction method is a feasible option following resection
of osteosarcoma in distal femur.
At present, the most popular biological reconstruction
method following skeletal tumor resection is allografting
[16-19]. However, there are problems relating to infec-
tious transmission, immunological reaction and refusal
based on social or religious beliefs especially in Asian
countries. Allograft reconstruction for extremity sarco-
mas had a high rate of adverse events (70%) and allograft
removal (60%) in patients followed for at least 10 years
[20]. Under these circumstances, recycled tumor bone
autografts are widely used as an alternative to bone allo-
grafts. Devitalized bone autograft is particularly well
suited in the region where allografts are not readily
available [21]. Techniques that are capable of destroying
tumor cells in resected bone include (1) irradiation
[17,19], (2) autoclaving [22], (3) pasteurization [2,23], (4)
freezing-thawing with liquid nitrogen [24] and alcohol
inactivation [25,26].
Compared to other methods, alcohol inactivation method
is considered on the same level of safety in oncological con-
trol, which superiorities are economic-applicable to patients
and the well fitness of bone graft with the defect. The dis-
advantage of alcohol-inactivated autograft is that it needs a
long time to accomplish revascularization and to integrate
with surrounding bone. The rationality of alcohol inactiva-
tion is that alcohol could devitalize the tumor bone shell.
The tumor cells had been devitalized when the ingrowth of
surrounding vessels occurred [5]. Our previous studies
showed that continuous bone callus presented after 8 weeks
and complete bony healing showed after 12 weeks in rabbit
femur [27]. The irradiated allograft presented the likely
bony healing process of creeping substitution with the bone
formation rate of 1 cm per 10 months [21]. In our previous
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the dynamic imaging observation and ISOLS compos-
ite scoring, the new bone originated from host bone
and the bone healing time in femur is about 4 to
6 months and that in tibia about 6–8 months [6]. We hold
the viewpoint that creeping substitution is possibly the
main way in bony junction and the healing time in femur
is faster than that in tibia.
As we known, there is no reports concerned the joint
function and QOL between alcohol-inactivated replanta-
tion alone and mega-prosthesis. Biological reconstruc-
tion, using distraction osteogenesis or frozen autografts,
could yield good functional results and QOL without
leading to an increase in the incidence of local recur-
rence [28]. After retrospective review of 20 patients who
underwent primary osteoarticular allograft reconstruc-
tion after extremity sarcoma resection, it was concluded
that functional outcomes of patients with intact osteoar-
ticular allografts were comparable to outcomes with
prostheses replacement [20]. In this study, the results
showed that prosthesis could achieve better functional
results than alcohol-inactivated autograft in less than
2 years. In over 2 years, there is no difference on joint
function and QOL. Alcohol-inactivated replantation
could result in comparable clinical outcomes with mega-
prostheses.
The emotional well-being in bone cancers patient
populations has received minimal attention [29]. Robert
et al. [29] reported that better leg function was significantly
related to better emotional functioning in long-term osteo-
sarcoma survivors. O’Malley et al. [30] examined 115
pediatric cancer survivors and did not find a relationship
between physical function and psychological adjustment
following cancer. In this study, no relationship could be
found between functional results and QOL. Other limita-
tions in this study are, small amount of patients, the less
than 10 years’ follow-up, retrospective study design, variety
among tumor size and use of chemotherapy protocols,
which might result in biased result. The multi-centric ran-
domized controlled study with large samples should be
considered.
Conclusion
Biological reconstruction with alcohol-inactivated auto-
graft could avoid prosthesis related complications and
achieved comparable results with prosthesis. This re-
construction method is a feasible option following re-
section of osteosarcoma in distal femur. Different
reconstruction options could be chosen according to
tumor location, such as the distance to Insall line. If
possible, the reconstruction allowing the maximal ar-
ticulation preservation should be selected after care-
ful evaluation of the effects of chemotherapy and the
location of the tumor.Competing interests
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